MI - Nursing Case Study
Pathophysiology
• Primary mechanism: Coronary artery occlusion due to atherosclerotic plaque rupture leads to reduced blood flow, causing myocardial tissue ischemia and subsequent necrosis.
• Secondary mechanism: Platelet aggregation and thrombus formation at the site of plaque rupture exacerbate occlusion, intensifying ischemia and tissue damage.
• Key complication: If not promptly managed, ischemia can lead to heart muscle cell death, impaired cardiac function, and potential heart failure or arrhythmias.
Patient Profile
Demographics:
62-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe chest pain radiating to the left arm
• Key symptoms: Shortness of breath, sweating, nausea, palpitations
• Vital signs: Blood pressure 145/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.6°C, oxygen saturation 91% on room air
Section 1
As the medical team continues to assess the patient, new diagnostic results provide further insight into his condition. An electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads, confirming an acute ST-elevation myocardial infarction (STEMI). Cardiac biomarkers, including troponin levels, are significantly elevated, indicating myocardial injury. A chest X-ray shows mild pulmonary congestion, suggesting some degree of heart failure due to impaired cardiac function. Given the patient's history of hypertension, diabetes, and hyperlipidemia, these findings are consistent with a high risk for cardiovascular complications.
The patient's clinical status begins to change as he develops additional symptoms. Despite receiving supplemental oxygen, his oxygen saturation remains low at 89%, and he exhibits increased respiratory distress, with a respiratory rate now at 28 breaths per minute. He also reports worsening chest pain, rated 9 out of 10 on the pain scale, despite ongoing intravenous nitroglycerin therapy. Auscultation reveals bilateral crackles in the lung bases, indicating worsening pulmonary edema. These signs suggest that the patient's cardiac function is further compromised, likely due to the size and location of the myocardial infarction.
In response to these developments, the medical team escalates care. The patient is transferred to the cardiac intensive care unit for closer monitoring and advanced management. A decision is made to proceed with urgent coronary angiography to identify the site of occlusion and potential revascularization. This will help prevent further myocardial damage and address the ischemic complications. The team remains vigilant for potential arrhythmias, a common complication post-MI, and prepares for possible interventions such as percutaneous coronary intervention (PCI) to restore blood flow and mitigate the risk of heart failure progression.
Section 2
As the patient settles into the cardiac intensive care unit, the medical team conducts an initial assessment. Vital signs reveal a blood pressure of 95/60 mmHg, indicating hypotension, likely due to the combination of myocardial compromise and nitroglycerin therapy. Heart rate is elevated at 110 beats per minute, and the patient remains tachypneic with a respiratory rate of 30 breaths per minute. Oxygen saturation has improved slightly to 91% with high-flow oxygen, but the patient is still visibly in respiratory distress. Cardiac auscultation continues to reveal bilateral crackles at the lung bases, and there is mild jugular venous distention, suggesting the development of acute decompensated heart failure. The patient describes his chest pain as constant and oppressive, now accompanied by nausea and diaphoresis, indicative of ongoing ischemia.
The coronary angiography reveals a significant occlusion in the left anterior descending artery, confirming the need for urgent revascularization. The decision is made to proceed with percutaneous coronary intervention (PCI) to restore coronary blood flow. Despite this intervention, the patient exhibits new electrocardiogram changes, showing frequent premature ventricular contractions, raising concerns about the potential for more serious arrhythmias. Laboratory results show a further rise in troponin levels, now critical at 15 ng/mL, reflecting ongoing myocardial injury. B-type natriuretic peptide (BNP) is elevated at 900 pg/mL, corroborating the clinical picture of heart failure due to increased cardiac stress.
Throughout this process, the medical team remains focused on stabilizing the patient's hemodynamic status and monitoring for complications such as cardiogenic shock and arrhythmias. The patient is initiated on intravenous diuretics to manage pulmonary congestion and reduce cardiac preload. Continuous monitoring and reassessment are crucial as the team evaluates the effectiveness of interventions and adjusts the treatment plan. The next steps will be pivotal in determining the patient's recovery trajectory, with vigilant attention required to identify and address any emergent complications in this critical phase.
Section 3
As the medical team continues to monitor the patient post-PCI, there is a sudden change in the patient's status. The patient begins to experience increased chest pain, described as sharp and radiating to the left arm, accompanied by worsening dyspnea. His vital signs indicate a concerning shift: blood pressure has dropped further to 85/55 mmHg, heart rate remains elevated at 120 beats per minute, and oxygen saturation has decreased to 88% despite high-flow oxygen therapy. The patient appears more diaphoretic and pale, and his mental status is slightly altered, indicating potential hypoperfusion.
The urgent need for bedside echocardiography is identified to assess cardiac function more precisely. The echocardiogram reveals a marked decrease in left ventricular ejection fraction to 30%, consistent with significant myocardial dysfunction. There is also evidence of a new regional wall motion abnormality, suggesting the possibility of ongoing ischemia or infarction in the myocardium despite the recent PCI. The team suspects the development of cardiogenic shock, a severe complication necessitating immediate intervention to support cardiac output and tissue perfusion.
In response to these findings, the medical team initiates an infusion of inotropic support to enhance cardiac contractility and improve perfusion. Vasopressors are also considered to maintain adequate blood pressure. The patient is closely monitored for changes in hemodynamic parameters and signs of organ dysfunction. As the team works to stabilize the patient, they remain vigilant for the potential need for mechanical circulatory support, such as an intra-aortic balloon pump, should the patient's condition fail to improve with pharmacological interventions. The next steps will be critical in determining the patient's prognosis and guiding further management in this complex clinical scenario.
Section 4
As the medical team administers inotropic support to the patient, they notice some initial improvement in his hemodynamic parameters. The blood pressure begins to stabilize slightly, rising to 95/60 mmHg, and his heart rate decreases to 110 beats per minute, suggesting a partial response to the intervention. However, despite these changes, his oxygen saturation remains low at 88%, and his respiratory effort continues to be labored. This prompts further investigation into potential pulmonary complications, and a chest X-ray is promptly ordered.
The chest X-ray reveals bilateral pulmonary edema, indicative of worsening heart failure and fluid overload, which is contributing to the patient's persistent dyspnea and low oxygen saturation. Additionally, laboratory results return, showing elevated levels of cardiac biomarkers, including troponin, confirming ongoing myocardial injury. The patient's renal function tests reveal a concerning rise in creatinine levels, suggesting impaired kidney function likely due to inadequate perfusion, a common complication of cardiogenic shock.
In light of these findings, the medical team adjusts their management plan. Diuretics are initiated to address the pulmonary edema and support renal function by reducing preload and improving fluid balance. The team also increases the dosage of inotropic support to enhance cardiac contractility further. Continuous monitoring of the patient's response to these interventions is crucial, as they remain vigilant for any signs of deterioration that may necessitate more advanced measures, such as mechanical circulatory support. The next steps will focus on optimizing the patient's hemodynamic status and preventing further organ dysfunction, as the team works to stabilize the patient and improve his overall prognosis.
Section 5
As the medical team continues to manage the patient's condition, they observe his response to the adjusted interventions. Initially, there is a modest improvement in his clinical status. The diuretics seem to be effective, as evidenced by an increase in urine output, which suggests a reduction in fluid overload. His respiratory effort appears to ease slightly, and his oxygen saturation improves to 92% with supplemental oxygen. The heart rate stabilizes further, reducing to 100 beats per minute, and blood pressure maintains at 100/65 mmHg, indicating a more stable hemodynamic state. These changes suggest that the adjustments in treatment are having a positive impact, though the team remains cautious due to the complexity of his condition.
However, new complications arise as further laboratory tests and clinical assessments reveal ongoing challenges. The patient's renal function continues to be of concern, as creatinine levels have not yet improved and remain at 2.5 mg/dL, indicating persistent renal impairment. Additionally, the electrolytes show an imbalance, with hypokalemia emerging as a potential issue due to the diuretic therapy, with potassium levels dropping to 3.0 mEq/L. Recognizing the risk of electrolyte disturbances, the team promptly initiates potassium supplementation and adjusts the diuretic regimen to prevent further depletion.
Despite these efforts, the patient begins to exhibit signs of increased fatigue and mental confusion, raising concerns about potential cerebral hypoperfusion. Neurological assessments reveal sluggish pupillary reactions and a mild decrease in Glasgow Coma Scale score, now at 13. This change in neurological status prompts the team to consider further diagnostic testing, including a CT scan of the head, to rule out any acute intracranial events. The team remains vigilant, as they balance the need for aggressive intervention with the risk of further complications, constantly evaluating the effectiveness of their management plan to optimize the patient's recovery trajectory.